Elsevier

Transplantation Proceedings

Volume 41, Issue 6, July–August 2009, Pages 2159-2162
Transplantation Proceedings

Renal transplantation
Complication: Other problem
Increase in Malignancies as Cause of Death in Renal Transplant Patients

https://doi.org/10.1016/j.transproceed.2009.05.029Get rights and content

Abstract

The Andalusian Kidney Transplant Registry is a Public Health Service Regional Registry of Andalusia, Spain. We have analyzed the causes of death among 5599 kidney transplantations performed between January 1, 1984 and December 31, 2007. The total number of patients who died after renal transplantation was 1106. Of these, 656 patients died with functioning renal grafts, which constituted the group analyzed in this study. No significant differences in the causes of death were observed as a function of age, sex, retransplant status, cause of end-stage renal disease, diabetes, and duration of the previous renal replacement therapy. Infections were the most frequent cause of death in the first year posttransplantation (early deaths). A significant difference was observed when these early deaths were compared with those that occurred after the first year posttransplantation (late deaths); there were fewer deaths due to infections (40.4% vs 15.9%, early vs late) and more deaths from cancer (4.9% vs 23.7%). The causes of death in the period 1984–1995 were compared with those in 1996–2007, excluding the deaths that occurred more than 12 years posttransplantation (not possible in the 1996–2007 periods n = 583). The causes of early death did not change. A significant difference was observed among late deaths with an increase in infections (14% vs 17%) and cancers (20% vs 29.7%). Thus, malignancies became the most frequent cause of late death in the 1996–2007 period. In conclusion, in our region, a long-term change in renal transplant patient mortality is taking place, with a significant increase in deaths due to cancer.

Section snippets

Patients and Methods

Andalusia is a region in the south of Spain with a population of approximately 8 million. Since 1984, the data of all patients who have received hemodialysis, peritoneal dialysis, or a kidney transplant in Andalusia have been collected into a computerized registry. Patient variables have included age, sex, cause of end-stage renal disease (ESRD), viral hepatitis serology, previous renal replacement therapy (RRT) type and extent, organ origin (deceased or living donor), combined solid organ

Results

The total number of patients who died after renal transplantation was 1106, including 656 who died with functioning renal grafts, which constituted the group analyzed in this study. The most frequent cause of death among these 656 patients was cardiovascular disease (n = 184; 28%), followed by infections (n = 149; 22.7%) and malignancies (n = 121; 18.4%), whereas hepatic diseases (n = 37; 5.6%), other (n = 102; 15.5%), and unknown (n = 63; 9.6%) were less prevalent. No significant differences

Discussion

The survival of renal transplant recipients has shown considerable improvement in recent years. This observation is probably due to more experience with pre- and posttransplant clinical management. In particular, it is due to advances in immunosuppressive and antibiotic therapies, in surgical techniques, and in medical treatment of cardiovascular risk factors. The causes of graft loss have also changed over time; currently, death with a functioning graft constitutes one of the principal causes

References (7)

There are more references available in the full text version of this article.

Cited by (19)

  • Determinants of Successful Use of Sirolimus in Renal Transplant Patients

    2020, Transplantation Proceedings
    Citation Excerpt :

    Death due to infections was rare in our patient cohort, with 7.5% compared with 22% to 23% in the aforementioned [24] and another large registry study [25]. One explanation is that infection-related death is more prevalent early after transplantation [26], and SRL initiation in our patient cohort occurred on average 6 years after transplantation. Graft failure was responsible for one fourth of therapy failures and occurred in 15% of the whole study cohort, which is comparable with rates of 11% to 17% from reports of smaller studies [27,28].

  • Renal transplant among type 1 and type 2 diabetes patients in Spain: A population-based study from 2002 to 2013

    2017, European Journal of Internal Medicine
    Citation Excerpt :

    We detected significant increases in infections over time. Previous research had reported that infections were the most frequent cause of death (> 40%) in the first year post-transplantation despite improvements in treatment and prophylaxis, perhaps due to the use of more powerful immunosuppressive protocols [20]. In spite of this, we are showing decreasing trends in mortality rates during admission for RTx.

View all citing articles on Scopus

This work was supported by grants for data collection from Astellas, Novartis, Roche-Farma, Wyeth, and Genzyme.

View full text